country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-N12250

Copy Link Print Information

7-Deoxynarciclasine

Name: 7-Deoxynarciclasine
Brand: MedChemExpress
SKU: HY-N12250
Price: 360.00 USD
Availability: InStock
Rating: 5 (1 reviews)

Kundenbewertung

Based on 1 Customer Validation

7-Deoxynarciclasine (compound 2b) can be isolated from Hymenocallis littoralis. 7-Deoxynarciclasine inhibits the cancer cell growth.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 98.61%
CAS. Nr.: 19622-83-4
Formel: C₁₄H₁₃NO₆
Molecular Weight:291.26

Speicherung:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

7-Deoxynarciclasine Chemical Structure

CAS. Nr.: 19622-83-4

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

7-Deoxynarciclasine (compound 2b) can be isolated from Hymenocallis littoralis. 7-Deoxynarciclasine inhibits the cancer cell growth^[1].

Cellular Effect

Cell Line	Type	Value	Description	References
BXPC-3	GI₅₀	0.07 μg/mL Compound: 1b	Cytotoxicity against human sBxPC-3 cells Cytotoxicity against human sBxPC-3 cells	[PMID: 15730244]
DU-145	GI₅₀	0.051 μg/mL Compound: 1b	Cytotoxicity against human DU145 cells Cytotoxicity against human DU145 cells	[PMID: 15730244]
DU-145	GI₅₀	0.062 μg/mL Compound: 2b	Growth inhibition of human DU145 cells Growth inhibition of human DU145 cells	[PMID: 16441059]
Huh-7	CC₅₀	7.2 μM Compound: 1	Cytotoxicity against human Huh7.5 cells treated after 96 hrs by MTT assay Cytotoxicity against human Huh7.5 cells treated after 96 hrs by MTT assay	[PMID: 23511018]
Huh-7	EC₅₀	0.55 μM Compound: 1	Antiviral activity against Hepatitis C virus infected in human Huh7.5 cells after 96 hrs by fluorescence microscopic analysis Antiviral activity against Hepatitis C virus infected in human Huh7.5 cells after 96 hrs by fluorescence microscopic analysis	[PMID: 23511018]
KM-20L2	GI₅₀	0.084 μg/mL Compound: 1b	Cytotoxicity against human KM20L2 cells Cytotoxicity against human KM20L2 cells	[PMID: 15730244]
KM-20L2	GI₅₀	0.15 μg/mL Compound: 2b	Growth inhibition of human KM20L2 cells Growth inhibition of human KM20L2 cells	[PMID: 16441059]
MCF7	GI₅₀	0.046 μg/mL Compound: 1b	Cytotoxicity against human MCF7 cells Cytotoxicity against human MCF7 cells	[PMID: 15730244]
MCF7	GI₅₀	0.093 μg/mL Compound: 2b	Growth inhibition of human MCF7 cells Growth inhibition of human MCF7 cells	[PMID: 16441059]
NCI-H460	GI₅₀	0.053 μg/mL Compound: 1b	Cytotoxicity against human NCI-H460 cells Cytotoxicity against human NCI-H460 cells	[PMID: 15730244]
NCI-H460	GI₅₀	0.11 μg/mL Compound: 2b	Growth inhibition of human NCI-H460 cells Growth inhibition of human NCI-H460 cells	[PMID: 16441059]
P388	ED₅₀	<0.01 μg/mL Compound: 2b	Growth inhibition of mouse P388 cells Growth inhibition of mouse P388 cells	[PMID: 16441059]
P388	ED₅₀	0.019 μg/mL Compound: 1b	Cytotoxicity against mouse P388 cells Cytotoxicity against mouse P388 cells	[PMID: 15730244]
SF-268	GI₅₀	0.12 μg/mL Compound: 1b	Cytotoxicity against human SF-268 cells Cytotoxicity against human SF-268 cells	[PMID: 15730244]
Vero	IC₅₀	0.042 μg/mL Compound: 2, Lycoricidine	Antiviral activity against Punta Toro virus Adames infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by MTT assay Antiviral activity against Punta Toro virus Adames infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by MTT assay	[PMID: 1336040]
Vero	IC₅₀	0.053 μg/mL Compound: 2, Lycoricidine	Antiviral activity against Yellow fever virus Ashibi infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by MTT assay Antiviral activity against Yellow fever virus Ashibi infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by MTT assay	[PMID: 1336040]
Vero	IC₅₀	0.056 μg/mL Compound: 2, Lycoricidine	Antiviral activity against Japanese encephalitis virus Nakayama infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by MTT assay Antiviral activity against Japanese encephalitis virus Nakayama infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by MTT assay	[PMID: 1336040]
Vero	IC₅₀	0.058 μg/mL Compound: 2, Lycoricidine	Antiviral activity against Sandfly fever sicilian virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by MTT assay Antiviral activity against Sandfly fever sicilian virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by MTT assay	[PMID: 1336040]
Vero	IC₅₀	0.059 μg/mL Compound: 2, Lycoricidine	Antiviral activity against Dengue virus type 4 infected in african green monkey Vero cells after 6 days by plaque reduction assay Antiviral activity against Dengue virus type 4 infected in african green monkey Vero cells after 6 days by plaque reduction assay	[PMID: 1336040]
Vero	IC₅₀	0.15 μg/mL Compound: 2, Lycoricidine	Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay	[PMID: 1336040]

Chemical Information

CAS. Nr. 19622-83-4
Appearance Solid
Molecular Weight 291.26
Formel C₁₄H₁₃NO₆
Color Light yellow to light brown
SMILES

O=C1C2=CC(OCO3)=C3C=C2C4=C[C@H](O)[C@@H](O)[C@@H](O)[C@]4([H])N1
Structure Classification
- Alkaloids
- Quinoline Alkaloids
Initial Source
Versand

Room temperature in continental US; may vary elsewhere.

Speicherung

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (269 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. George R. Pettit, et al. Isolation and Structural Modification of 7-Deoxynarciclasine and 7-Deoxy-trans-Dihydronarciclasine†. J. Nat. Prod. 2006, 69.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen